Ocugen, Inc.

NASDAQ:OCGN

Biotechnology

Healthcare
$0.74 +2.46%

+$0.03 today

Market cap
$250.82M
Beta
2.21
P/E (TTM)
-5.6
EPS (TTM)
-$0.22
52W Low $0.90High $2.73

Volume 5.83M

Average 7.51M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$56.96M

FY 2025 · Annual

Investing Cash Flow

-$311,000.00

FY 2025 · Annual

Financing Cash Flow

$17.33M

FY 2025 · Annual

-73.3% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(58.37M)(86.8M)(63.08M)(54.05M)(67.85M)
Depreciation & Amortization229K480K704K1.97M2.39M
Deferred Income Tax(52K)0000
Stock-Based Compensation6.96M10.54M9.22M7.43M7.71M
Change in Working Capital2.49M9.2M(13.16M)3.67M(523K)
Accounts Receivables00000
Inventory00000
Accounts Payables3.5M0000
Other Working Capital(1.01M)9.2M(13.16M)3.67M(523K)
Other Non-Cash Items799K6.51M4.26M(1.15M)1.31M
Operating Cash Flow(47.94M)(60.08M)(62.05M)(42.14M)(56.96M)
Capital Expenditures(939K)(4.46M)(10.48M)(3.39M)(185K)
Acquisitions (Net)00000
Purchases of Investments0(13.27M)(3.95M)00
Sales of Investments0017.5M00
Other Investing Activities(877K)761K00(126K)
Investing Cash Flow(1.82M)(16.97M)3.08M(3.39M)(311K)
Debt Repayment(10K)500K500K30M(1M)
Common Stock Issued129.21M59.57M20.8M38.56M18.33M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(8.53M)(592K)(68K)(3.7M)0
Financing Cash Flow120.68M59.48M20.88M64.86M17.33M
Effect of Forex Changes(325)25K(5K)28K13K
Net Change in Cash70.92M(17.55M)(38.1M)19.36M(39.93M)
Free Cash Flow(48.88M)(64.54M)(72.53M)(45.53M)(57.15M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$67.8M
+ D&A$2.4M
+ Stock-Based Comp$7.7M
+ Deferred Tax$0
- Working Capital-$523.0K
+ Other Non-Cash$1.3M
= Operating Cash Flow-$57.0M
- Capex-$185.0K
= Free Cash Flow-$57.1M

Analysis

FY2025 free cash flow is -$57.1M. FCF conversion is 84.2% of net income. Operating cash flow was -$57.0M, with capex of -$185.0K. The largest bridge item is Stock-Based Comp at $7.7M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 10, 2026
DEFA14ADEFA14A filingNov 6, 2026
DEFA14ADEFA14A filingNov 6, 2026
10-QQuarterly reportNov 4, 2026
8-KCurrent reportNov 4, 2026

Does OCGN generate free cash flow?

Ocugen, Inc. (OCGN) generated -$57.15M of free cash flow in fiscal 2025.

How much operating cash flow does OCGN produce?

Operating cash flow was -$56.96M, before capital expenditures of $185,000.00.